In this live discussion with QIAGEN research experts, we will summarize the findings of the ELIMA study that have been described in detail in the podcast and science talks over the course of this Cancer Insights Session. We will also look at each part of the workflow for analyzing extracellular vehicles, circulating tumor cells and cfDNA in parallel, and the tools we can use for further analysis of the data. This will include targeted DNA sequencing using UMIs, bioinformatics solutions, targeted methylated-DNA sequencing, miRNA sequencing and simultaneous DNA and RNA profiling by NGS. We will put a spotlight on collection and stabilization of blood samples to enable multianalyte approaches in liquid biopsy and will discuss the need for standardization of methods for validation of biomarkers from basic research to clinical research – standardization is key. Throughout the discussion you will be invited to ask questions using the chat function.